8.1 Prevention, screening and management of common coinfections
Consolidated ARV guidelines, June 2013
8.1.1 Co-trimoxazole preventive therapy
Co-trimoxazole preventive therapy (CPT) should be implemented as an integral component of a package of HIV-related services. Existing recommendations cover initiation of co-trimoxazole preventive therapy among adults, adolescents, pregnant women and children for prevention of Pneumocystis pneumonia, toxoplasmosis and bacterial infections, as well as benefits for malaria prophylaxis and discontinuation of cotrimoxazole preventive therapy.
Source of recommendations
Guidelines on co-trimoxazole prophylaxis for HIV-related infection among children, adolescents and adults: recommendations for a public health approach
These recommendations will be updated in 2014.
Key selected existing recommendations
Table 8.1 shows the recommendations. Refer to the Web Annex for methodology used in rating the quality of evidence.